Medusa Pharmaceuticals Analysis: $14 Raised
What is Medusa Pharmaceuticals?
Repurposed drug combinations to combat antimicrobial resistance
Location
Cambridge, United Kingdom
Employees
1-10
Founded
2021
Product Features & Capabilities
- Synergistic drug combinations to restore antibiotic efficacy
- Repurposed drug pairings for AMR treatment
Use Cases
Restore penicillin effectiveness against resistant strains; Enhance treatment of tuberculosis with existing drugs; Improve outcomes for cystic fibrosis patients with Pseudomonas aeruginosa
Other Considerations
Imperial College London spin-out; Focus on AMR with global health impact; Addresses a growing threat of 1 million annual deaths from AMR
See something that needs updating? Suggest edits to this profile.